SAM
ZBH icon

Stansberry Asset Management’s Zimmer Biomet ZBH Stock Holding History

Stansberry Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-95,916
Closed -$11.8M – 108
2021
Q4 		$11.8M Buy
95,916
+19,819
+26% +$2.59M 1.9% 16
2021
Q3 		$10.8M Buy
+76,097
New +$11.2M 2.17% 19

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stansberry Asset Management's ZBH Position: Q1 2022 in Review

Stansberry Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 95,916 shares — an estimated $11.8M sold.

Stansberry Asset Management first reported a position in ZBH in Q3 2021 and held it in 2 quarters. The position peaked at $11.8M in Q4 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

  • Stansberry Asset Management reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
  • Stansberry Asset Management sold 95,916 Zimmer Biomet shares in Q1 2022, an estimated $11.8M.
  • Stansberry Asset Management first reported a position in Zimmer Biomet in Q3 2021 and held it in 2 quarters.
  • Stansberry Asset Management's Zimmer Biomet position peaked at $11.8M in Q4 2021.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Stansberry Asset Management's 13F filing for Q1 2022, filed 16 May 2022.